| Long name: |
VSIG4 Antibody |
| Antigen: |
VSIG4 |
| Other names: |
Ig superfamily protein, Protein Z39Ig, V-set and immunoglobulin domain containing 4, V-set and immunoglobulin domain-containing protein 4, V-set and immunoglobulin domain-containing protein 4, complement receptor of the immunoglobulin superfamily, mRNA, protein Z39Ig, Homo sapiens V-set and immunoglobulin domain containing 4 |
| Gene name: |
VSIG4, VSIG4 |
| Gene synonims: |
CRIg, CRIg, VSIG4, Z39IG, Z39IG, VSIG4 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Mouse (Mus musculus) |
| Specificity: |
VSIG4, This is an antibody designed to detect VSIG4 |
| Purification method: |
Antigen Affinity method, Caprylic Acid Ammonium Sulfate Precipitation, etc, The most common purification methods used in the antibody production are Affinity Chromatography |
| Form/Appearance: |
02% NaN3, VSIG4 antibody purified by protein affinity column containing 1% BSA and 0 |
| Concentration: |
100ug/200ul |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
EIA, ELI-Spot, IFA, Western Blot (WB), ELISA |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
VSIG4 |
| Short name: |
Anti- VSIG4 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to V-set and immunoglobulin domain containing 4 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CRIg and Z39IG, Plasma membranes, VSIG4 and IDBG-637672 and ENSBTAG00000015769 and 614262, VSIG4 and IDBG-73541 and ENSG00000155659 and 11326, Vsig4 and IDBG-160903 and ENSMUSG00000044206 and 278180, alternative pathway and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0032703 and negative regulation of interleukin-2 production and biological process this GO :0042130 and negative regulation of T cell proliferation and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, protein binding, this GO :0005515 and protein binding and molecular function this GO :0006957 and complement activation, this GO :0005515 : protein binding, this GO :0005515 : protein binding, V-set and immunoglobulin domain containing 4 |
| Identity: |
17032 |
| Gene: |
VSIG4 |
More about : VSIG4 |
| Long gene name: |
V-set and immunoglobulin domain containing 4 |
| Synonyms: |
Z39IG |
| Locus: |
Xq12 |
| Discovery year: |
2004-09-10 |
| GenBank acession: |
AJ132502 |
| Entrez gene record: |
11326 |
| Pubmed identfication: |
11004523 17016555 17016562 |
| RefSeq identity: |
NM_007268 |
| Classification: |
V-set domain containing Immunoglobulin like domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000021727 |
| Locus Specific Databases: |
Mental Retardation database |